On this episode of Managed Care Cast, Sarah Carroll, MPH, director of the Center for Care Transformation at AVIA, discusses the challenges of implementing digital health in underserved populations and the potential of these solutions to better address health disparities in the United States.
The COVID-19 pandemic has brought disparities in health care to the forefront of the national conversation and simultaneously jump-started widespread use of telehealth and digital solutions to address newly formed health care access gaps.
But even before the pandemic began, the Center for Care Transformation at AVIA was helping members move from reactive, episodic, and uncoordinated care to proactive, longitudinal, and efficient care.
AVIA, a network of 50 leading health systems brought together in a collaborative membership model, offers a range of digital solutions to drive clinical, operational and financial results.
On this episode of Managed Care Cast, we speak with Sarah Carroll, MPH, director of the Center for Care Transformation at AVIA, about the challenges of implementing digital health in underserved populations and the potential of these solutions to better address health disparities in the United States.
Listen above or through one of these podcast services:
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More